Pharma Pulse 3/24/25: Strategies to Address Rising Medication Costs, Optum Rx Changes How Pharmacies Are Reimbursed & more

News
Article

The latest news for pharma industry insiders.

Strategies to Address Rising Medication Costs & Improve Patient Access

Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, identifies innovative strategies and solutions for addressing the rising cost of medications and improving patient access.

Optum Rx Changes How Pharmacies Are Reimbursed

Optum Rx's new cost-based program uses an internal algorithm that leverages multiple available industry data sources, such as NADAC and PAC, to inform reimbursement.

Alnylam Heart Drug Approval Sets Up Challenge With Pfizer

Alnylam Pharmaceuticals Inc. won expanded US approval for a heart drug that could be the biggest boon yet for the 23-year-old biotech — if it can beat out stiff competition from the likes of Pfizer Inc.

Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years

Johnson & Johnson has announced manufacturing, research and development, and technology investments of more than $55 billion in the United States over the next four years. This represents a 25% increase in investment compared to the previous four years and builds upon the Company’s already elevated U.S. investment levels resulting from the passage of the 2017 Tax Cuts & Jobs Act.

MJH Life Sciences on LinkedIn

🚀 We are thrilled to announce the launch of Scout, our new AI-powered search tool designed to transform how the oncology community accesses critical clinical insights, on OncLive.

Scout leverages a customized large language model (LLM) to offer healthcare professionals a smarter way to get answers to complex clinical questions. With our extensive library of expert-backed content and insights from leaders in the field, Scout delivers personalized, high-quality results with incredible speed and accuracy.

Why Scout?
It’s not just a search tool—it’s a game-changer for health care professionals who need access to actionable, relevant clinical information. By processing vast amounts of data and learning patterns within the content, Scout understands the context of each query, returning highly precise and tailored results.

By tapping into the Scout ecosystem, partners can offer their stakeholders an advanced tool that provides cutting-edge, AI-powered access to expert content. Scout is another way we’re leading the way in AI adoption within the healthcare space.
🎯 Test Scout today and see how it can benefit your work.https://lnkd.in/eTcnYdA4

#AI #Oncology #HealthTech #MedicalInnovation #ClinicalInsights #ML #HealthcareProfessionals #MJHBrand #MJHxOncLive

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs

© 2025 MJH Life Sciences

All rights reserved.